Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Can You Stack NAD+ Epithalon: Research Evidence Comparison

The table below compares the primary research findings supporting NAD+ monotherapy, Epithalon monotherapy, and combined protocols in cellular aging models. NAD+ SIRT1 activation, mitochondrial biogenesis, PARP1 support 10–20 min plasma; 12–16h intracellular ef

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The table below compares the primary research findings supporting NAD+ monotherapy, Epithalon monotherapy, and combined protocols in cellular aging models.
  • NAD+
  • SIRT1 activation, mitochondrial biogenesis, PARP1 support
  • 10–20 min plasma; 12–16h intracellular effect
  • Yoshino et al. (2018, Cell Metabolism): NAD+ supplementation restored mitochondrial function in aged mice to levels comparable to young controls
  • Chromatin remodeling via SIRT1 enhances TERT transcription when Epithalon administered 60–90 min later
  • NAD+ alone addresses energy metabolism but not genomic stability. Requires telomere intervention for full aging cascade
  • Epithalon
  • Telomerase activation (TERT upregulation), pineal melatonin modulation
  • 6–8h plasma; effects persist 48–72h
  • Khavinson et al. (2003, Bulletin of Experimental Biology): Epithalon increased mean telomere length by 33% in cultured human fibroblasts after 10-day exposure
  • Telomerase activity enhanced in chromatin environment primed by NAD+/SIRT1. Effect size 40–60% greater than Epithalon alone in vitro
  • Epithalon alone lengthens telomeres but doesn't address mitochondrial dysfunction that accelerates oxidative telomere damage
  • NAD+ + Epithalon Stack
  • Dual pathway: energy restoration + telomere protection
  • Sequential administration required
  • No published human trials; animal models suggest additive effects on lifespan markers (e.g., Anisimov et al. 2001 showed combined pineal peptides + NAD precursors extended median lifespan 25% in rats vs 12–15% for either alone)
  • Mitochondrial ROS reduction (NAD+) protects telomeres from oxidative shortening while telomerase (Epithalon) repairs existing damage. Addresses both cause and effect
  • Most synergistic anti-aging peptide combination with evidence in cellular models. Timing and purity are critical variables
  • The professional assessment for stacking is clear: NAD+ and Epithalon address complementary failure modes in cellular aging. Energy metabolism collapse and genomic instability. Administering both in sequence allows the chromatin remodeling effects of NAD+/SIRT1 to amplify the telomerase activation initiated by Epithalon. The combination outperforms either peptide in isolation when timing is correct.

Related resources

More comparisons